These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24389613)

  • 1. [In vitro and in silico approaches to evaluate usefulness and safety of chemical compounds applied or exposed on skin].
    Sugibayashi K; Todo H; Kadhum WR
    Yakugaku Zasshi; 2014; 134(1):27-32. PubMed ID: 24389613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmeceuticals: What's Real, What's Not.
    Draelos ZD
    Dermatol Clin; 2019 Jan; 37(1):107-115. PubMed ID: 30466682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Technological development of alternative method to animal experiments in Japan].
    Miyazaki H; Yoshiyama Y
    Nihon Yakurigaku Zasshi; 2018; 151(2):48-51. PubMed ID: 29415924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico cancer research towards 3R.
    Jean-Quartier C; Jeanquartier F; Jurisica I; Holzinger A
    BMC Cancer; 2018 Apr; 18(1):408. PubMed ID: 29649981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The science of dermocosmetics and its role in dermatology.
    Dreno B; Araviiskaia E; Berardesca E; Bieber T; Hawk J; Sanchez-Viera M; Wolkenstein P
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1409-17. PubMed ID: 24684296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
    Ottaviani G; Martel S; Carrupt PA
    J Med Chem; 2007 Feb; 50(4):742-8. PubMed ID: 17300161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Science for supporting the functionality and safety of cosmetics].
    Ikarashi Y; Hara S
    Yakugaku Zasshi; 2014; 134(1):25-6. PubMed ID: 24389612
    [No Abstract]   [Full Text] [Related]  

  • 8. Alternative test models for skin ageing research.
    Nakamura M; Haarmann-Stemmann T; Krutmann J; Morita A
    Exp Dermatol; 2018 May; 27(5):495-500. PubMed ID: 29478289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guiding principles for the implementation of non-animal safety assessment approaches for cosmetics: skin sensitisation.
    Goebel C; Aeby P; Ade N; Alépée N; Aptula A; Araki D; Dufour E; Gilmour N; Hibatallah J; Keller D; Kern P; Kirst A; Marrec-Fairley M; Maxwell G; Rowland J; Safford B; Schellauf F; Schepky A; Seaman C; Teichert T; Tessier N; Teissier S; Weltzien HU; Winkler P; Scheel J
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):40-52. PubMed ID: 22374415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cosmeceuticals for men.
    de Lacerda D; Thioly-Bensoussan D; Burke K
    Cutis; 2013 Jul; Suppl():6-12. PubMed ID: 24308151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
    Förster M; Bolzinger MA; Fessi H; Briançon S
    Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An 8-week face-split study to evaluate the efficacy of cosmeceuticals using non-invasive bioengineering devices.
    Jung JW; Lee YW; Choe YB; Ahn KJ
    Skin Res Technol; 2013 Aug; 19(3):324-9. PubMed ID: 23480308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical model to predict skin concentration after topical application of drugs.
    Todo H; Oshizaka T; Kadhum WR; Sugibayashi K
    Pharmaceutics; 2013 Dec; 5(4):634-51. PubMed ID: 24351574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
    Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database.
    Hoffmann S; Kleinstreuer N; Alépée N; Allen D; Api AM; Ashikaga T; Clouet E; Cluzel M; Desprez B; Gellatly N; Goebel C; Kern PS; Klaric M; Kühnl J; Lalko JF; Martinozzi-Teissier S; Mewes K; Miyazawa M; Parakhia R; van Vliet E; Zang Q; Petersohn D
    Crit Rev Toxicol; 2018 May; 48(5):344-358. PubMed ID: 29474128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mushroom ethanolic extracts as cosmeceuticals ingredients: Safety and ex vivo skin permeation studies.
    Taofiq O; Rodrigues F; Barros L; Barreiro MF; Ferreira ICFR; Oliveira MBPP
    Food Chem Toxicol; 2019 May; 127():228-236. PubMed ID: 30922966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cosmeceutical realm.
    Draelos ZD
    Clin Dermatol; 2008; 26(6):627-32. PubMed ID: 18940543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cosmeceuticals today].
    Puchkova TV; Ivanova ES
    Vopr Kurortol Fizioter Lech Fiz Kult; 2010; (6):43-7. PubMed ID: 21381331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmeceuticals for children: should you care?
    Pham AK; Dinulos JG
    Curr Opin Pediatr; 2014 Aug; 26(4):446-51. PubMed ID: 24977686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicles: Potential nano carriers for the delivery of skin cosmetics.
    Lohani A; Verma A
    J Cosmet Laser Ther; 2017 Dec; 19(8):485-493. PubMed ID: 28753057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.